Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes

Diego Chillón-Pino1, Mihaly Badonyi1, Colin A Semple1

  • 1MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

Cell Reports
|October 23, 2024
PubMed

Insights

This study analyzed millions of cancer mutations using protein structures. Tumor suppressor genes show damaging mutations, while oncogenes have milder, clustered mutations, aiding driver gene identification.

Area of Science:

  • Genomics
  • Structural Biology
  • Cancer Research

Background:

  • Protein structure determination and modeling enable large-scale analysis of human genetic variants.
  • Understanding the structural context of mutations is crucial for cancer research.

Purpose of the Study:

  • To analyze millions of cancer-associated missense mutations based on structural locations and predicted effects.
  • To identify distinct patterns distinguishing tumor suppressors and oncogenes.
  • To develop methods for identifying candidate cancer driver genes.

Main Methods:

  • Analysis of millions of cancer-associated missense mutations.
  • Assessment of mutation structural locations and predicted perturbative effects.
  • Evaluation of collective protein mutation properties and three-dimensional clustering.

Main Results:

  • Tumor suppressors are enriched in structurally damaging mutations (loss-of-function).
  • Oncogene mutations are typically structurally mild, favoring gain-of-function.
  • Three-dimensional mutation clustering is highly predictive for oncogenes, distinguishing them from non-cancer genes.

Conclusions:

  • Distinct structural mutation patterns differentiate tumor suppressors and oncogenes.
  • Structural analysis, particularly mutation clustering, aids in identifying cancer driver genes.
  • Findings offer utility for analyzing cancer sequencing data and understanding molecular roles.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K